JPS5069045A - - Google Patents

Info

Publication number
JPS5069045A
JPS5069045A JP49088920A JP8892074A JPS5069045A JP S5069045 A JPS5069045 A JP S5069045A JP 49088920 A JP49088920 A JP 49088920A JP 8892074 A JP8892074 A JP 8892074A JP S5069045 A JPS5069045 A JP S5069045A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP49088920A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5069045A publication Critical patent/JPS5069045A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP49088920A 1973-08-02 1974-08-02 Pending JPS5069045A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3669173A GB1451798A (en) 1973-08-02 1973-08-02 Prostanoic acid derivatives

Publications (1)

Publication Number Publication Date
JPS5069045A true JPS5069045A (ja) 1975-06-09

Family

ID=10390378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49088920A Pending JPS5069045A (ja) 1973-08-02 1974-08-02

Country Status (24)

Country Link
US (1) US3954881A (ja)
JP (1) JPS5069045A (ja)
AR (1) AR204013A1 (ja)
AT (1) AT341119B (ja)
BE (1) BE818396A (ja)
CH (1) CH605511A5 (ja)
CS (1) CS174785B2 (ja)
DD (1) DD114401A5 (ja)
DE (1) DE2437388A1 (ja)
DK (1) DK410174A (ja)
EG (1) EG11489A (ja)
ES (1) ES428889A1 (ja)
FI (1) FI232274A7 (ja)
FR (1) FR2239995B1 (ja)
GB (1) GB1451798A (ja)
IE (1) IE40157B1 (ja)
IL (1) IL45299A (ja)
IN (1) IN138940B (ja)
LU (1) LU70639A1 (ja)
NL (1) NL7410343A (ja)
NO (1) NO742713L (ja)
SE (1) SE7409930L (ja)
ZA (1) ZA744509B (ja)
ZM (1) ZM12074A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07165703A (ja) * 1993-08-03 1995-06-27 Alcon Lab Inc 緑内障及び高眼圧治療用局所眼薬組成物
WO1998034916A1 (fr) * 1997-02-10 1998-08-13 Ono Pharmaceutical Co., Ltd. Derives de 11,15-o-dialkylprostaglandine e, leur procede de production, et medicaments renfermant ceux-ci comme principe actif
JP2004346080A (ja) * 1992-09-21 2004-12-09 Allergan Inc 医薬としての非酸性シクロペンタンヘプタン酸,2−シクロアルキルまたはアリールアルキル誘導体
JP2005527467A (ja) * 2001-08-29 2005-09-15 ネオーズ テクノロジーズ, インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468830A (en) * 1974-01-26 1977-03-30 May & Baker Ltd Cyclopentane derivatives
US4183870A (en) * 1974-01-26 1980-01-15 May & Baker Limited Cyclopentane derivatives
GB1506816A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
NL7605381A (nl) * 1975-05-26 1976-11-30 Schering Ag Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
US4388457A (en) * 1982-02-11 1983-06-14 University Patents, Inc. Phyllanthostatin compounds
CA2049359A1 (en) * 1989-03-28 1990-09-29 Leslie A. Freiberg Erythromycin derivatives
US6184250B1 (en) 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US5721273A (en) 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
EP1771066A2 (en) 2004-07-13 2007-04-11 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 glp-1
EP3061461A1 (en) 2004-10-29 2016-08-31 ratiopharm GmbH Remodeling and glycopegylation of fibroblast growth factor (fgf)
US7932236B2 (en) * 2004-11-09 2011-04-26 Seneb Biosciences, Inc. Glycolipids
NZ556436A (en) 2005-01-10 2010-11-26 Biogenerix Ag Glycopegylated granulocyte colony stimulating factor
US9187546B2 (en) 2005-04-08 2015-11-17 Novo Nordisk A/S Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
US9187532B2 (en) 2006-07-21 2015-11-17 Novo Nordisk A/S Glycosylation of peptides via O-linked glycosylation sequences
WO2008057683A2 (en) 2006-10-03 2008-05-15 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
BRPI0809670A8 (pt) 2007-04-03 2018-12-18 Biogenerix Ag métodos para aumentar a produção de célula tronco, para aumentar o número de granulócitos em um indivíduo, para prevenir, tratar e aliviar a mielossupressão que resulta de uma terapia contra o câncer, para tratar uma condição em um indivíduo, para tratar neutropenia e trombocitopenia em um mamífero, para expandir células tronco hematopoiéticas em cultura, para aumentar a hematopoiese em um indivíduo, para aumentar o número de célulars progenitoras hematopoiéticas em um indivíduo, e para fornecer enxerto estável da medula óssea, e, forma de dosagem oral.
MX2009013259A (es) 2007-06-12 2010-01-25 Novo Nordisk As Proceso mejorado para la produccion de azucares de nucleotidos.
RU2573587C2 (ru) 2008-02-27 2016-01-20 Ново Нордиск А/С Конъюгированные молекулы фактора viii
EP2410846B1 (en) 2009-03-25 2016-09-07 Seneb Biosciences, Inc. Glycolipids as treatment for disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1334952A (en) * 1971-01-06 1973-10-24 Ici Ltd Cyclopentane derivat-ves and a process for their manufacture

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004346080A (ja) * 1992-09-21 2004-12-09 Allergan Inc 医薬としての非酸性シクロペンタンヘプタン酸,2−シクロアルキルまたはアリールアルキル誘導体
JPH07165703A (ja) * 1993-08-03 1995-06-27 Alcon Lab Inc 緑内障及び高眼圧治療用局所眼薬組成物
WO1998034916A1 (fr) * 1997-02-10 1998-08-13 Ono Pharmaceutical Co., Ltd. Derives de 11,15-o-dialkylprostaglandine e, leur procede de production, et medicaments renfermant ceux-ci comme principe actif
JP2005527467A (ja) * 2001-08-29 2005-09-15 ネオーズ テクノロジーズ, インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物

Also Published As

Publication number Publication date
IL45299A (en) 1978-06-15
ZA744509B (en) 1975-07-30
DD114401A5 (ja) 1975-08-05
NL7410343A (nl) 1975-02-04
FI232274A7 (ja) 1975-02-03
AT341119B (de) 1978-01-25
DK410174A (ja) 1975-04-01
ATA635674A (de) 1977-05-15
IN138940B (ja) 1976-04-17
BE818396A (fr) 1975-02-03
ES428889A1 (es) 1976-09-01
ZM12074A1 (en) 1976-11-22
AU7163574A (en) 1976-01-29
DE2437388A1 (de) 1975-02-13
FR2239995B1 (ja) 1978-07-21
IE40157B1 (en) 1979-03-28
IE40157L (en) 1975-02-02
GB1451798A (en) 1976-10-06
IL45299A0 (en) 1974-10-22
AR204013A1 (es) 1975-11-12
LU70639A1 (ja) 1974-12-10
FR2239995A1 (ja) 1975-03-07
NO742713L (ja) 1975-03-03
SE7409930L (ja) 1975-02-03
US3954881A (en) 1976-05-04
CH605511A5 (ja) 1978-09-29
CS174785B2 (ja) 1977-04-29
EG11489A (en) 1978-06-30

Similar Documents

Publication Publication Date Title
AR201758A1 (ja)
AU465372B2 (ja)
AR201235Q (ja)
FR2239995B1 (ja)
AU465453B2 (ja)
AU465434B2 (ja)
AU450229B2 (ja)
AU477823B2 (ja)
AR195948A1 (ja)
AU461342B2 (ja)
AU447540B2 (ja)
AR201432A1 (ja)
AR210729A1 (ja)
AR193950A1 (ja)
AU1891376A (ja)
AR196123Q (ja)
CH566110A5 (ja)
BG19676A1 (ja)
CH564639A5 (ja)
CH563577A5 (ja)
CH563215A5 (ja)
CH560846A5 (ja)
CH560488A5 (ja)
CH500073A4 (ja)
BG21404A3 (ja)